Elite Pharmaceuticals, Inc.
OTC: ELTP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nasrat Hakim
- Employees
- 64
- Headquarters
- Northvale, United States
- IPO year
- 2000
- Market cap
- $398.4M
- Website
- https://www.elitepharma.com
Loading ELTP…
Loading profile data…Frequently asked questions about ELTP
What does Elite Pharmaceuticals, Inc. (ELTP) do?
Elite Pharmaceuticals, Inc. (ELTP) is a specialized pharmaceutical company focused on the creation and manufacturing of generic medications, as well as oral, controlled-release drug formulations. Its business activities are primarily divided into two segments: Abbreviated New Drug Applications (ANDAs) for generic products and New Drug Applicatio...
Where does ELTP trade?
Elite Pharmaceuticals, Inc. (ELTP) trades on the Other OTC.
What sector is ELTP in?
Elite Pharmaceuticals, Inc. (ELTP) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Elite Pharmaceuticals, Inc.?
Nasrat Hakim is the chief executive officer of Elite Pharmaceuticals, Inc. (ELTP).
Where is Elite Pharmaceuticals, Inc. headquartered?
Elite Pharmaceuticals, Inc. is headquartered in United States.
Does ELTP pay a dividend?
Elite Pharmaceuticals, Inc. (ELTP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELTP go public?
Elite Pharmaceuticals, Inc. (ELTP) completed its initial public offering in 2000.